Teriparatide
Forteo · rhPTH(1-34) · Recombinant PTH 1-34
Think of it as a bone-building coach for your skeleton.
Teriparatide is like a personal trainer for your bones. It encourages them to bulk up by signaling your body to build more bone than it breaks down. This can be especially helpful if you're dealing with bone thinning issues that make you prone to fractures.
Unlike other treatments that simply slow down bone loss, Teriparatide actively promotes new bone growth. It's a bit like flipping a switch that tells your body to focus on adding strength and density to your skeleton, which can help reduce the risk of fractures in areas like your spine and hips.
Who it's for
- Postmenopausal women worried about bone strength
- Active seniors looking to reduce fracture risk
- People with severe bone thinning issues
Probably not for you if…
- Anyone looking for a long-term solution beyond two years
- Those without a prescription from a healthcare provider
- People uncomfortable with daily injections
Editorial summary for research context · Not medical advice
Mechanism of Action
Teriparatide is a recombinant form of the biologically active N-terminal 34 amino acids of human parathyroid hormone (PTH 1-34). Unlike continuous PTH elevation, intermittent daily subcutaneous dosing preferentially activates osteoblasts over osteoclasts, producing net bone formation. Research has established increases in bone mineral density and reductions in vertebral and non-vertebral fracture risk in postmenopausal osteoporosis. Teriparatide is FDA-approved (Forteo) for severe osteoporosis and glucocorticoid-induced osteoporosis; prescription required. Cumulative lifetime use is capped at 2 years due to osteosarcoma signals in rat carcinogenicity studies.
Researched Benefits
Bone mineral density increase
Pivotal Phase 3 Fracture Prevention Trial demonstrated significant increases in lumbar spine and femoral neck BMD.
- [Neer et al. 2001]
Vertebral and non-vertebral fracture reduction
Daily SC teriparatide reduced new vertebral fractures by approximately 65% and non-vertebral fragility fractures in postmenopausal women.
- [Neer et al. 2001]
Anabolic (bone-forming) mechanism
Research distinguishes teriparatide from antiresorptive agents by direct osteoblast stimulation.
- [Hodsman et al. 2005]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
FDA-approved dosing (Forteo) — prescription required
- Dosage
- 20 mcg
- Frequency
- once daily
- Timing
- any time
- Cycle
- 104 weeks
FDA label: 20 mcg SC once daily; total cumulative lifetime use is capped at 2 years. Prescription and physician supervision required.
Reported Side Effects
- Orthostatic hypotension and dizziness, particularly after first doses
- Nausea and headache
- Leg cramps
- Transient post-dose hypercalcemia
- Injection-site reactions
- Osteosarcoma risk signal from rat carcinogenicity studies (basis for 2-year cumulative use cap)
Contraindications
- Conditions with increased baseline osteosarcoma risk (Paget's disease, prior skeletal radiation, open epiphyses)
- Preexisting hypercalcemia or primary hyperparathyroidism
- Severe renal impairment
- Pregnancy and lactation
- History of skeletal malignancy or bone metastases
Stacking Partners
Peptides commonly paired with Teriparatide in published research and protocol write-ups.
Vendor Pricing
No tracked vendors carry this peptide yet. Check back as we add more affiliate partners.
Gear + Companions
Reconstitution supplies and research-backed supplement companions for Teriparatide. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.
Gear you'll need
· Reconstitution + storage essentialsBacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
11:54The TRUTH About Osteoporosis and Osteopenia
Dr. Eric Berg DC
1.1M views · 11:54 · 2 years ago
5:58What They Aren't Telling You About Osteoporosis Medication
Dr. Lewis Clarke - Clarke Bioscience
242.6K views · 5:58 · 4 years ago
11:28Pharmacology - DRUGS FOR OSTEOPOROSIS (MADE EASY)
Speed Pharmacology
100.2K views · 11:28 · 2 years ago
5:54Osteoporosis Medications - Pharmacology - Musculoskeletal | @LevelUpRN
Level Up RN
95.1K views · 5:54 · 5 years ago
18:35Best Drugs for Osteoporosis or Pathway to Cancer? Forteo and Tymlos the Bone Building Drugs!
The Dr Doug Show | Longevity through Bone Health
45.2K views · 18:35 · 2 years ago
Research Papers
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
Neer RM, et al. · New England Journal of Medicine · 2001
PubMed 11346808 →Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use
Hodsman AB, et al. · Endocrine Reviews · 2005
PubMed 15798098 →



